Literature DB >> 24109433

Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells.

Chiara Verpelli1, Luigi Carlessi, Giulia Bechi, Elena Fusar Poli, Daniel Orellana, Christopher Heise, Silvana Franceschetti, Renato Mantegazza, Massimo Mantegazza, Domenico Delia, Carlo Sala.   

Abstract

Most human neuronal disorders are associated with genetic alterations that cause defects in neuronal development and induce precocious neurodegeneration. In order to fully characterize the molecular mechanisms underlying the onset of these devastating diseases, it is important to establish in vitro models able to recapitulate the human pathology as closely as possible. Here we compared three different differentiation protocols for obtaining functional neurons from human induced pluripotent stem cells (hiPSCs): human neural progenitors (hNPs) obtained from hiPSCs were differentiated by co-culturing them with rat primary neurons, glial cells or simply by culturing them on matrigel in neuronal differentiation medium, and the differentiation level was compared using immunofluorescence, biochemical and electrophysiological methods. We show that the differentiated neurons displayed distinct maturation properties depending on the protocol used and the faster morphological and functional maturation was obtained when hNPs were co-cultured with rat primary neurons.

Entities:  

Keywords:  Human neurons; induced pluripotent stem cells; neuronal differentiation; postsynapse; synapse formation

Year:  2013        PMID: 24109433      PMCID: PMC3791383          DOI: 10.3389/fncel.2013.00175

Source DB:  PubMed          Journal:  Front Cell Neurosci        ISSN: 1662-5102            Impact factor:   5.505


  53 in total

1.  Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis.

Authors:  Chiara Verpelli; Giovanni Piccoli; Cristina Zibetti; Alice Zanchi; Fabrizio Gardoni; Kun Huang; Dario Brambilla; Monica Di Luca; Elena Battaglioli; Carlo Sala
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

2.  Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells.

Authors:  Ernesto Lujan; Soham Chanda; Henrik Ahlenius; Thomas C Südhof; Marius Wernig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 3.  Synaptic vesicle trafficking and Parkinson's disease.

Authors:  Giovanni Esposito; Fernandes Ana Clara; Patrik Verstreken
Journal:  Dev Neurobiol       Date:  2012-01       Impact factor: 3.964

Review 4.  Dendritic spine pathology in neuropsychiatric disorders.

Authors:  Peter Penzes; Michael E Cahill; Kelly A Jones; Jon-Eric VanLeeuwen; Kevin M Woolfrey
Journal:  Nat Neurosci       Date:  2011-03       Impact factor: 24.884

5.  Variation in the safety of induced pluripotent stem cell lines.

Authors:  Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2009-07-09       Impact factor: 54.908

6.  Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.

Authors:  John T Dimos; Kit T Rodolfa; Kathy K Niakan; Laurin M Weisenthal; Hiroshi Mitsumoto; Wendy Chung; Gist F Croft; Genevieve Saphier; Rudy Leibel; Robin Goland; Hynek Wichterle; Christopher E Henderson; Kevin Eggan
Journal:  Science       Date:  2008-07-31       Impact factor: 47.728

7.  Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.

Authors:  Ningzhe Zhang; Mahru C An; Daniel Montoro; Lisa M Ellerby
Journal:  PLoS Curr       Date:  2010-10-28

8.  DNA-damage response, survival and differentiation in vitro of a human neural stem cell line in relation to ATM expression.

Authors:  L Carlessi; L De Filippis; D Lecis; A Vescovi; D Delia
Journal:  Cell Death Differ       Date:  2009-02-20       Impact factor: 15.828

9.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

10.  Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion.

Authors:  Ting Yuan; Wei Liao; Nian-Hua Feng; Yuan-Lei Lou; Xin Niu; Ai-Jun Zhang; Yang Wang; Zhi-Feng Deng
Journal:  Stem Cell Res Ther       Date:  2013-06-14       Impact factor: 6.832

View more
  17 in total

1.  Nisin and non-essential amino acids: new perspective in differentiation of neural progenitors from human-induced pluripotent stem cells in vitro.

Authors:  Elahe Eftekhari; Marzieh Ghollasi; Raheleh Halabian; Maryam Soltanyzadeh; Seyed Ehsan Enderami
Journal:  Hum Cell       Date:  2021-04-25       Impact factor: 4.174

2.  The X-Linked Intellectual Disability Protein IL1RAPL1 Regulates Dendrite Complexity.

Authors:  Caterina Montani; Mariana Ramos-Brossier; Luisa Ponzoni; Laura Gritti; Andrzej W Cwetsch; Daniela Braida; Yoann Saillour; Benedetta Terragni; Massimo Mantegazza; Mariaelvina Sala; Chiara Verpelli; Pierre Billuart; Carlo Sala
Journal:  J Neurosci       Date:  2017-06-02       Impact factor: 6.167

3.  Genetic and morphological features of human iPSC-derived neurons with chromosome 15q11.2 (BP1-BP2) deletions.

Authors:  D K Das; V Tapias; L D'Aiuto; K V Chowdari; L Francis; Y Zhi; Bhattacharjee A Ghosh; U Surti; J Tischfield; M Sheldon; J C Moore; K Fish; V Nimgaonkar
Journal:  Mol Neuropsychiatry       Date:  2015-06-24

4.  Choline Ameliorates Disease Phenotypes in Human iPSC Models of Rett Syndrome.

Authors:  Eunice W M Chin; Guillaume Marcy; Su-In Yoon; Dongliang Ma; Francisco J Rosales; George J Augustine; Eyleen L K Goh
Journal:  Neuromolecular Med       Date:  2016-07-05       Impact factor: 3.843

5.  Characterisation of neurons derived from a cortical human neural stem cell line CTX0E16.

Authors:  Greg W Anderson; P J Michael Deans; Ruth D T Taylor; Pooja Raval; Ding Chen; Harrison Lowder; Srishti Murkerji; Laura C Andreae; Brenda P Williams; Deepak P Srivastava
Journal:  Stem Cell Res Ther       Date:  2015-08-22       Impact factor: 6.832

Review 6.  Modeling physiological and pathological human neurogenesis in the dish.

Authors:  Vania Broccoli; Serena G Giannelli; Pietro G Mazzara
Journal:  Front Neurosci       Date:  2014-07-24       Impact factor: 4.677

7.  Functional and molecular defects of hiPSC-derived neurons from patients with ATM deficiency.

Authors:  L Carlessi; E Fusar Poli; G Bechi; M Mantegazza; B Pascucci; L Narciso; E Dogliotti; C Sala; C Verpelli; D Lecis; D Delia
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

8.  Neurosphere Based Differentiation of Human iPSC Improves Astrocyte Differentiation.

Authors:  Shuling Zhou; Karolina Szczesna; Anna Ochalek; Julianna Kobolák; Eszter Varga; Csilla Nemes; Abinaya Chandrasekaran; Mikkel Rasmussen; Susanna Cirera; Poul Hyttel; András Dinnyés; Kristine K Freude; Hasan X Avci
Journal:  Stem Cells Int       Date:  2015-12-21       Impact factor: 5.443

9.  Coenzyme A corrects pathological defects in human neurons of PANK2-associated neurodegeneration.

Authors:  Daniel I Orellana; Paolo Santambrogio; Alicia Rubio; Latefa Yekhlef; Cinzia Cancellieri; Sabrina Dusi; Serena G Giannelli; Paola Venco; Pietro G Mazzara; Anna Cozzi; Maurizio Ferrari; Barbara Garavaglia; Stefano Taverna; Valeria Tiranti; Vania Broccoli; Sonia Levi
Journal:  EMBO Mol Med       Date:  2016-10-04       Impact factor: 12.137

10.  Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice.

Authors:  C Vicidomini; L Ponzoni; D Lim; M J Schmeisser; D Reim; N Morello; D Orellana; A Tozzi; V Durante; P Scalmani; M Mantegazza; A A Genazzani; M Giustetto; M Sala; P Calabresi; T M Boeckers; C Sala; C Verpelli
Journal:  Mol Psychiatry       Date:  2016-03-29       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.